Chemotherapy - Mustargen
Generic Name: Mechlorethamine
Other Names: Nitrogen Mustard, Mustine
Mustargen is a chemotherapy drug that is administered for the treatment of lung cancer, breast cancer, and lymphomas. It functions as an alkylating agent, meaning it interferes with DNA reproduction and cell replication.
The drug is usually administered for the treatment of Hodgkin’s Lymphoma and Cutaneous T-Cell Lymphoma, a Non-Hodgkin’s Lymphoma. It is commonly used in conjunction with other chemotherapy drugs in the following regimens:
- MOPP (mustargen, oncovin, procarbazine, prednisone)
- Stanford-V (adriamycin, mustargen, bleomycin, vinblastine, oncovin, etoposide, prednisone)
Drug Administration
For the treatment of Hodgkin’s Disease, it is administered via an IV drip. The drug should only be injected into a vein, not an artery, as it can cause irritation. If redness or swelling occurs at the injection site, notify a doctor immediately.
For the treatment of Cutaneous T-Cell Lymphoma, it is applied as a topical cream to the skin to help with skin lesions.
Side Effects
Common side effects include vomiting, low blood counts, mouth sores, hair loss, and infertility. If the drug is used topically, then redness or dryness of the skin can occur.
Less common side effects include loss of appetite, tinnitus (ringing in the ears), taste changes, fever, and diarrhea. In some cases, patients may develop a secondary cancer, such as leukemia.
For more information on Hodgkin's Disease, please see the following pages:
- Adult Hodgkin's Lymphoma: Diagnosis
- Adult Hodgkin's Lymphoma: Treatment
- Adult Hodgkin's Lymphoma: Introduction
- Childhood Hodgkin's Lymphoma: Diagnosis
- Childhood Hodgkin's Lymphoma: Treatment
- Childhood Hodgkin's Lymphoma: Introduction
For more information on Non-Hodgkin Lymphoma, please see the following pages:
More Articles
More Articles
Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...
The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...
Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...
At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...
Site Beginnings
This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...
Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...
The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...
The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...
The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...
According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...
Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...
New research suggests that frontline radioimmunotherapy...
Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...
